The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Effect of Cognitive-Existential Group Therapy on Survival in Early-Stage Breast Cancer
Abstract
Purpose: Cognitive-existential group therapy (CEGT) was developed to improve mood and mental attitude toward cancer in women with early-stage breast cancer receiving adjuvant chemotherapy. Given the debate about group therapy's association with increased survival in women with metastatic breast cancer, we were curious to check its effect at a much earlier stage in the cancer journey. Patients and Methods: We randomly assigned 303 women with early-stage breast cancer who were receiving adjuvant chemotherapy to either 20 sessions of weekly group therapy plus three relaxation classes (n = 154) or to a control condition of three relaxation classes alone (n = 149). The primary outcome was survival. Results: CEGT did not extend survival; the median survival time was 81.9 months (95% CI, 64.8 to 99.0 months) in the group-therapy women and 85.5 months (95% CI, 67.5 to 103.6 months) in the control arm. The hazard ratio for death was 1.35 (95% CI, 0.76 to 2.39; P = .31). In contrast, histology and axillary lymph node status were significant predictors of survival. Low-grade histology yielded a hazard ratio of 0.342 (95% CI, 0.17 to 0.69), and axillary lymph node–negative status yielded a hazard ratio of 0.397 (95% CI, 0.20 to 0.78). Conclusion: CEGT does not prolong survival in women with early-stage breast cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Effect of Group Psychosocial Support on Survival in Metastatic Breast Cancer
Goodwin, P. J., Leszcz, M., Ennis, M., Koopmans, J., Vincent, L., Guther, H., Drysdale, E., Hundleby, M., Chochinov, H. M., Navarro, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011871 · Cited by 891
Influence of psychological response on survival in breast cancer: a population-based cohort study
Watson, M., Haviland, J., Greer, S., Davidson, J., & Bliss, J. (1999) · The Lancet · doi:10.1016/s0140-6736(98)11392-2 · Cited by 705
Cited by
Depression as a predictor of disease progression and mortality in cancer patients: A Meta‐Analysis
Satin, J. R., Linden, W., & Phillips, M. J. (2009) · Cancer · doi:10.1002/cncr.24561 · Cited by 972
Faller, H., Schuler, M., Richard, M., Heckl, U., Weis, J., & Küffner, R. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2011.40.8922 · Cited by 912
Giese-Davis, J., Collie, K., Rancourt, K. M. S., Neri, E., Kraemer, H. C., & Spiegel, D. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.4455 · Cited by 458
Death anxiety and its role in psychopathology: Reviewing the status of a transdiagnostic construct
Iverach, L., Menzies, R. G., & Menzies, R. E. (2014) · Clinical Psychology Review · doi:10.1016/j.cpr.2014.09.002 · Cited by 459
“…therapeutic approaches have shown promise in the treatment of death anxiety in end-of-life care, including Dignity Therapy, Meaning-Centered Therapy, and Cognitive-Existential Group Therapy (Barrera & Spiegel, 2014; Breitbart et al., 2000; Chochinov et al., 2004; Kissane et al., 2004).”
BackgroundComparing Hospice and Nonhospice Patient Survival Among Patients Who Die Within a Three-Year Window
Connor, S. R., Pyenson, B., Fitch, K., Spence, C., & Iwasaki, K. (2007) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2006.10.010 · Cited by 422
Metadata
- Authors
- Kissane, D. W., Love, A., Hatton, A., Bloch, S., Smith, G., Clarke, D. M., Miach, P., Ikin, J., Ranieri, N., & Snyder, R. D.
- Venue
- Journal of Clinical Oncology
- Published
- 2004-11-01
- Volume
- 22
- Issue
- 21
- Pages
- 4255-4260
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2145157416
- Cited by
- 164
- References
- 2
- FWCI
- 5.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.